Normokalemic periodic paralysis

Normokalemic periodic paralysis is a rare inherited neuromuscular disorder characterized by episodic attacks of muscle weakness or paralysis during which serum potassium levels remain within the normal range. This distinguishes it from the more commonly recognized hypokalemic and hyperkalemic forms of periodic paralysis. The condition primarily affects skeletal muscles, leading to episodes of flaccid weakness that can range from mild limb heaviness to complete paralysis of the limbs and trunk. Attacks may be triggered by rest after exercise, cold exposure, stress, or prolonged immobility, and can last from hours to days. Normokalemic periodic paralysis has historically been a subject of nosological debate, with some experts considering it a variant of hyperkalemic periodic paralysis rather than a fully distinct entity. Mutations in the SCN4A gene (encoding the skeletal muscle sodium channel Nav1.4) have been identified in some families, though genetic heterogeneity may exist. The condition typically presents in childhood or early adolescence, and attack frequency and severity can vary considerably among affected individuals. Over time, some patients may develop progressive fixed myopathy with permanent muscle weakness, particularly in proximal muscles. Treatment is largely symptomatic and preventive. Avoidance of known triggers is a cornerstone of management. Pharmacological options may include acetazolamide or other carbonic anhydrase inhibitors, which can reduce attack frequency in some patients. Sodium chloride administration has been reported to worsen attacks in some cases, which may help differentiate this condition from hypokalemic periodic paralysis. Potassium supplementation during attacks does not consistently improve symptoms, consistent with the normokalemic state. Regular monitoring for the development of fixed myopathy is recommended, and physical therapy may help maintain muscle function over time.

Common questions about Normokalemic periodic paralysis